California Stem Cell Agency Symposium: 'Vague Fears' vs. Potential Genetic Alteration of Human Race
By David Jensen,
California Stem Cell Report
| 06. 11. 2015
[Quotes CGS's Marcy Darnovsky]
Untitled Document
California’s $3 billion stem cell agency has called a high-level meeting for next fall to examine a "red-hot" issue that many prominent researchers say could lead ultimately to alteration of the human race.
The topic is a technique that makes it much easier to alter the genetic make-up of individuals in a way that can be inherited by their offspring.
In April, scientists in China reported genetically modifying human embryos in what was regarded as a “world first.” (See
here and
here.)
More recently
Marcy Darnovsky, executive director of the
Center for Genetics and Society in Berkeley,
wrote on May 28 about how the subject was viewed at a meeting called, “Biotech and the Ethical Imagination: A Global Summit.”
“The far end of techno-enthusiastic perspectives, both on human germline modification specifically and on biotech in general, was represented by Harvard experimental psychologist and popular science writer Steven Pinker. In...
Related Articles
By Mariella Bodemeier Loayza Careaga, The Scientist | 03.15.2024
Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.
Humans are never alone. Even in a room devoid of other people, they are always in the company of billions of microscopic beings...
By Gerry Smith, Bloomberg | 03.12.2024
When Celenise Mahmood first learned about two new gene therapies that could cure sickle cell disease, she felt a wave of relief.
Her 9-year-old son, Navid, has the inherited blood disorder. By age 5, he’d had over 30 life-saving blood...
By Carol Cardona and Michelle Kromm, Scientific American | 03.11.2024
By Nada Hassanein, New Jersey Monitor | 03.14.2024
The U.S. Food and Drug Administration late last year approved two breakthrough gene therapies for sickle cell disease patients. Now a new federal program seeks to make these life-changing treatments available to patients with low incomes — and it could...